German Telecom Services and Carriers Stock News

Dividend move puts Elmos Semiconductor in focus Elmos Semiconductor (XTRA:ELG) has drawn fresh investor attention after announcing an annual dividend of €1.50 per share, payable on June 1, 2026, with an ex date of May 28 and a record date of May 29. See our latest analysis for Elmos Semiconductor. The €120.0 share price sits on the back of steady momentum, with a 9.69% 1 month share price return, a 29.03% 3 month share price return and a 68.03% 1 year total shareholder return, pointing to...

In recent months, Allianz has been refining its portfolio and risk profile through new joint ventures and partnerships in reinsurance and technology, set against sector-wide shifts in insurance demand and interest-rate conditions. This ongoing repositioning highlights how Allianz is responding to emerging risks such as cyber and AI, potentially reshaping its business mix and long-term operating model. Next, we’ll examine how Allianz’s push into reinsurance and technology partnerships might...

Carl Zeiss Meditec (XTRA:AFX) cut its revenue outlook after a weak start to the year, citing softer sales expectations in the US and China as well as pressure from China’s new volume based procurement process. See our latest analysis for Carl Zeiss Meditec. The revenue guidance cut and first quarter net loss arrived after a sharp reset in sentiment, with a 30 day share price return of 32% decline and a 1 year total shareholder return of 50.65% decline, signalling fading momentum despite...

Volkswagen, ticker XTRA:VOW3, has overtaken Tesla as Europe's top selling battery electric vehicle brand. The company is also involved in EU China discussions on electric vehicle import tariffs, including matters related to its Cupra brand. These developments affect Volkswagen's position in the European EV market and its approach to cross border sales with China. Volkswagen is a major global automaker with a growing focus on fully electric models, and its brands now play a central role in...

Siemens (XTRA:SIE) is back in focus after raising its fiscal 2026 earnings outlook, supported by a first quarter that exceeded expectations and by strong demand related to artificial intelligence and data center infrastructure. See our latest analysis for Siemens. The latest earnings beat and 2026 guidance upgrade come after a strong run, with the 90 day share price return of 12.58% and a 1 year total shareholder return of 13.84% pointing to momentum that has been building over several years,...

Deutsche Bank has reached a confidential settlement with former manager Stefano Foresti in a lawsuit tied to the Monte dei Paschi accounting scandal. The agreement concludes the first of several related cases brought by former employees over their alleged involvement in the affair. The outcome may influence how remaining internal disputes linked to the scandal are handled. For you as an investor looking at XTRA:DBK, this legal development comes with the share price at €29.6. The stock has...

Key Insights Friedrich Vorwerk Group's significant public companies ownership suggests that the key decisions are...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

With its stock down 15% over the past three months, it is easy to disregard CTS Eventim KGaA (ETR:EVD). But if you pay...

Why Verbio’s latest earnings are in focus Verbio (XTRA:VBK) is back in the spotlight after its second quarter and half year results to 31 December 2025 showed quarterly profitability, higher sales, and increased bioethanol and biomethane production. Those headline figures, together with an earlier share price move ahead of the announcement, have drawn fresh attention from investors who are assessing how the company’s fuel mix and operating scale are affecting the quality of its earnings. See...

Future Market Insights projects the global sphingolipids market to reach USD 1,145.6 million by 2035, and Merck KGaA (XTRA:MRK) is identified as a key supplier of high purity sphingolipid products and delivery systems. See our latest analysis for Merck KGaA. Merck KGaA’s role in the sphingolipids market sits against a backdrop of a €127.8 share price, a 10.41% 90 day share price return, and a 5.36% year to date share price return. At the same time, the 1 year total shareholder return of a...

In early February 2026, Nordex SE reported new European onshore wind orders totaling 220 MW across the UK, Turkiye, Lithuania and Sweden, all bundled with multi-year service and maintenance agreements that aim to secure long-term turbine performance in both standard and cold-climate sites. These contracts highlight Nordex’s growing strength in cold-climate and community wind projects, where its anti-icing technology and long-duration service deals are becoming central to how it competes for...

HelloFresh (XTRA:HFG) is back in focus after its share price dropped sharply, following a reported 9% year on year net revenue decline and missed Q4 2025 guidance that rattled investor confidence. See our latest analysis for HelloFresh. The recent Q4 2025 miss and profit warnings have been reflected in the numbers, with a 7 day share price return of 13.86% and a year to date share price return of 11.88%. Over a longer horizon, the 1 year total shareholder return of 58.47% and 5 year total...

In recent days, Deutsche Lufthansa was hit by a 24-hour strike by pilots and cabin crew over pensions and retirement funding, forcing the cancellation of close to 800 flights and disrupting travel for about 100,000 passengers, although the airline aimed to restore a largely normal schedule by the following day. This industrial action underscores persistent labor cost and pension pressures at Lufthansa, raising questions about how reliably the airline can control its core cost base while...

Infineon Technologies (XTRA:IFX) is in focus after reporting first quarter 2026 results and pairing them with fresh sales guidance for the second quarter and full fiscal year, giving investors updated benchmarks to assess. See our latest analysis for Infineon Technologies. The results and guidance have landed against a backdrop of solid recent momentum, with a 23.28% 90 day share price return and a 16.93% 1 year total shareholder return suggesting sentiment has strengthened over both shorter...

If you are wondering whether PUMA's current share price really reflects the business, you are not alone. This article is built to help you frame that question clearly. PUMA recently closed at €23.45, with returns of 3.3% over 7 days, 5.0% over 30 days and 4.7% year to date, while the 1 year, 3 year and 5 year returns stand at a 19.4% decline, 59.3% decline and 71.6% decline. Recent coverage around PUMA has focused on how the brand is positioned against global sportswear peers and how...

Earnings and contract wins set the tone for investors thyssenkrupp nucera KGaA (XTRA:NCH2) has drawn attention after first quarter earnings showed lower sales and a small net loss, while management reiterated full year guidance and announced a large electrolyzer contract in the Middle East. See our latest analysis for thyssenkrupp nucera KGaA. At a share price of €9.37, the stock has a 1-day share price return of 2.69% and a 90-day share price return of 12.22%. The 1-year total shareholder...

Bayer (XTRA:BAYN) is back in focus after reporting Phase III OCEANIC-STROKE data for its investigational Factor XIa inhibitor asundexian, showing a 26% reduction in recurrent ischemic strokes without a clear rise in major bleeding. See our latest analysis for Bayer. Those OCEANIC-STROKE results land at a time when Bayer’s share price has already been gathering pace, with a 30 day share price return of 10.36% and a 90 day share price return of 61.89%. Meanwhile, the 1 year total shareholder...

Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been...

SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) defied analyst predictions to release its first-quarter results, which were...

Recent commentary around SAP (XTRA:SAP) has focused on better-than-expected 2025 operating profit, sustained customer demand, and a cluster of cloud and AI partnerships that some investors see as underappreciated by the market. See our latest analysis for SAP. Despite a busy few weeks that included new AI partnerships, a Defense Innovation Hub launch, and fresh collaborations with firms like KPMG and Cohere, SAP’s share price return has been soft. The 30 day share price return shows a decline...

Siemens Healthineers AG has reported past first-quarter 2026 results, with sales of €5,402 million and net income of €449 million, both slightly lower than the prior year. The small step down in revenue and earnings highlights how even modest shifts in quarterly performance can matter for a business built on high-value diagnostic and imaging solutions. We’ll now examine how this modest year-on-year earnings softness influences Siemens Healthineers’ investment narrative built around...

Carl Zeiss Meditec (XTRA:AFX) Q1 2026 Results in Focus Carl Zeiss Meditec (XTRA:AFX) has opened its 2026 financial year with Q1 results that put revenue and EPS front and center, with the latest reported quarter showing €627.5 million in revenue and basic EPS of €0.59, alongside net income of €51.8 million. The company has seen revenue move from €579.6 million and basic EPS of €0.70 in Q4 2024 to €627.5 million and €0.59 in Q4 2025, while trailing 12 month basic EPS sat at €1.61 on €2.23...

Germany’s decision to approve a $129 billion defense budget for 2026, a 45% increase over 2025, immediately draws attention to how this larger procurement pipeline could influence Rheinmetall (XTRA:RHM) and its role in European rearmament. See our latest analysis for Rheinmetall. At a share price of €1,609.0, Rheinmetall’s recent 1 day share price return of 1.87% sits against a 30 day share price return of a 15.27% decline. Its 1 year total shareholder return of 97.94% and very large 5 year...